SCHEDULE: Franklin Resources Maintains 16% Stake in Achieve Life Sciences
Beneficial Ownership Amendment
Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. report a continued 16.0% beneficial ownership stake in Achieve Life Sciences, Inc., including shares from warrant exercise.
Summary
- Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. collectively hold 8,640,039 shares of Achieve Life Sciences, Inc. Common Stock.
- This represents 16.0% of the total class of securities.
- The reported beneficial ownership includes 4,181,025 shares of Common Stock issuable upon the exercise of warrants.
- Franklin Advisers, Inc. holds sole voting and dispositive power over all 8,640,039 shares.
- Charles B. Johnson and Rupert H. Johnson, Jr., while principal shareholders of Franklin Resources, Inc., report 0% direct beneficial ownership in Achieve Life Sciences, Inc.
- Two specific funds, Franklin Biotechnology Discovery Fund (a U.S. registered investment company) and Franklin Biotechnology Discovery Fund (a Luxembourg registered SICAV), hold significant interests of 8.3% (4,476,098 shares) and 7.7% (4,163,770 shares) respectively, within the reported aggregate.
Sentiment
Score: 6
Explanation: The filing is a routine beneficial ownership disclosure, indicating a significant, continued stake by a major institutional investor. While not directly financial performance, a large, stable institutional holding can be viewed as a positive signal of long-term interest.
Positives
- A significant institutional investor, Franklin Resources, Inc., through its subsidiaries, maintains a substantial 16.0% beneficial ownership stake in Achieve Life Sciences, Inc., indicating continued investment interest and confidence in the company.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure Compliance | Amendment No. 3 to Schedule 13G filed by Franklin Resources, Inc. and related entities, fulfilling beneficial ownership reporting requirements under Rule 13d-1(b). | 2025-06-30 | Enhances transparency regarding significant institutional ownership, aligning with regulatory mandates for public companies. |
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 2015-10-13 | Date of Limited Power of Attorney for Franklin Templeton Investment Funds. |
| 2024-10-31 | Date of previous Schedule 13G/A No. 1 filing (incorporated by reference for Limited Powers of Attorney). |
| 2025-06-30 | Date of event which requires filing of this statement. |
| 2025-08-01 | Signature date of the Schedule 13G Amendment No. 3. |
Recommendation
holdThis Schedule 13G Amendment primarily serves as a disclosure of a significant beneficial ownership stake by Franklin Resources, Inc. and its subsidiaries in Achieve Life Sciences, Inc. While the filing itself does not contain financial performance data or strategic updates, the continued holding of a 16.0% stake by a prominent institutional investor suggests a sustained long-term interest in the company. Without additional financial or operational context, a 'hold' recommendation is appropriate, as this filing indicates stability in a major shareholder's position rather than a catalyst for immediate price movement.
Keywords
Achieve Life Sciences, Franklin Resources, Franklin Advisers, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Biotechnology, Investment Fund, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.